PVI
NVAX icon

Pura Vida Investments’s Novavax NVAX Stock Holding History

Pura Vida Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-327,800
Closed -$1.3M – 121
2019
Q4 		$1.3M Hold
327,800
– – 0.11% 88
2019
Q3 		$1.65M Hold
327,800
– – 0.28% 71
2019
Q2 		$1.92M Buy
+327,800
New +$2.58M 0.29% 85

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's NVAX Position: Q3 2021 in Review

Pura Vida Investments sold out of Novavax (NVAX) in Q3 2021, closing a stake of 10,000 shares — an estimated $2.12M sold.

Pura Vida Investments first reported a position in NVAX in Q2 2021 and held it in 1 quarter. The position peaked at $2.12M in Q2 2021. 443 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.

  • Pura Vida Investments reported no remaining Novavax position as of Q3 2021 after selling out during the quarter.
  • Pura Vida Investments sold 10,000 Novavax shares in Q3 2021, an estimated $2.12M.
  • Pura Vida Investments first reported a position in Novavax in Q2 2021 and held it in 1 quarter.
  • Pura Vida Investments's Novavax position peaked at $2.12M in Q2 2021.
  • 443 funds tracked by Wall St. Rank held Novavax as of Q3 2021.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.